Response to letter regarding article, "warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (birmingham atrial fibrillation treatment of the aged study)".

Eitemau Tebyg

• Warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (Birmingham Atrial Fibrillation Treatment of the Aged Study).
  gan: Mavaddat, N, et al.
  Cyhoeddwyd: (2014)
• Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.
  gan: Mant, J, et al.
  Cyhoeddwyd: (2007)
• Warfarin versus aspirin for prevention of cognitive decline in an elderly community population with atrial fibrillation (the BAFTA Study): a randomised controlled trial
  gan: Mavaddat, N, et al.
  Cyhoeddwyd: (2013)
• Cost effectiveness of warfarin versus aspirin in patients older than 75 years with atrial fibrillation.
  gan: Jowett, S, et al.
  Cyhoeddwyd: (2011)
• Is warfarin a safe alternative to aspirin in elderly patients with atrial fibrillation?
  gan: Mant, J, et al.
  Cyhoeddwyd: (2008)